Dr. Daniel Amen shares his BRIGHTMINDS approach for preventing Alzheimer's, addressing 11 risk factors including blood flow, ...

While dementia and Alzheimer’s disease are terms that are often used interchangeably, they don’t mean the same thing.

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA approves a ...

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...

Can a diet actually keep the brain strong and lower dementia risk? Evidence suggests the so-called ‘Mind diet’ might ...

The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment INDIANAPOLIS, ...

The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...

A single, freely available, noninvasive brain scan done in just a few minutes during midlife can predict what chronic ...

Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced it plans to offer laboratory testing based on the ...

People in early stages of the disease may show other signs of cognitive deterioration such as being unable to follow ...

UCLA Health researchers mapped four distinct pathways leading to Alzheimer’s disease using electronic health records.   The ...